The level of serum anti-Müllerian hormone correlates with vitamin D status in men and women but not in boys.

What Was Tested

This clinical trial looks at Vitamin D, K2, Magnesium and Zinc.

The objective of the study was to determine whether serum levels of AMH are related to 25-hydroxyitamin D [25(OH)D)] status.

Why It Was Studied

Anti-Müllerian hormone (AMH) is a gonad-specific hormone, which is extensively used as a marker of gonadal status.

The level of serum AMH has a high variance in similar individuals for reasons that are unknown.

Who Took Part

By PubMed's age tags, the people studied were young children, children, young adults, adults, middle-aged adults, older adults and people over 80, both men and women.

Three cohorts of participants were analyzed; mature men (n = 113), premenopausal women (n = 33), and 5- to 6-yr-old boys (n = 74).

How the Study Was Run

The design is described as placebo-controlled.

A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.

This was a correlative and intervention study.

What Was Measured

The level of serum AMH has a high variance in similar individuals for reasons that are unknown.

The AMH gene promoter contains a vitamin D response element that may cause vitamin D status to influence serum AMH levels.

PubMed files the paper under topics including Age Factors, Aging, Anti-Mullerian Hormone, Cohort Studies, Health Status, Seasons and Sex Characteristics.

What This Means in Plain Language

The paper is a placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.

Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2012 (The Journal of clinical endocrinology and metabolism), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.